Overview of insulin delivery pen devices

2007 McMahon, 2007, Inhaled insulin for diabetes mellitus, N Engl J Med., 356, 497, 10.1056/NEJMct063533 Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care., 27, 1047, 10.2337/diacare.27.5.1047 Hogan, 2003, American Diabetes Association. Economic costs of diabetes in the US in 2002, Diabetes Care., 26, 917, 10.2337/diacare.26.3.917 Nathan, 2006, Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care., 29, 1963, 10.2337/dc06-9912 2009, American Diabetes Association. Standards of medical care in diabetes: 2009, Diabetes Care., 32, S13 2007, AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus, Endocr Pract., 13, 1 Jellinger, 2007, Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force, Endocr Pract., 13, 260, 10.4158/EP.13.3.260 Hoerger, 2008, Is glycemic control improving in the U.S, adults? Diabetes Care., 31, 81, 10.2337/dc07-1572 Riddle, 2002, The underuse of insulin therapy in North America, Diabetes Metab Res Rev., 18, S42, 10.1002/dmrr.277 Peyrot, 2005, Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study, Diabetes Care., 28, 2673, 10.2337/diacare.28.11.2673 Funnell, 2007, Overcoming barriers to the initiation of insulin therapy, Clinical Diabetes., 25, 36, 10.2337/diaclin.25.1.36 Korytkowski, 2005, FlexPen: addressing issues of confidence and convenience in insulin delivery, Clin Ther., 27, S89, 10.1016/j.clinthera.2005.11.019 Da Costa, 2002, A comparison of insulin pen use in the United States and the United Kingdom, Diabetes Educ., 28, 52, 10.1177/014572170202800106 Vázquez-Carrera, 2004, Insulin analogues in the management of diabetes, Methods Find Exp Clin Pharmacol., 26, 445, 10.1358/mf.2004.26.6.831318 Horvath, 2007, Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus, Cochrane Database Syst Rev., 2, CD005613 Home, 2006, Insulin detemir: from concept to clinical experience, Expert Opin Pharmacother., 7, 325, 10.1517/14656566.7.3.325 Raskin, 2005, Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs, Diabetes Care., 28, 260, 10.2337/diacare.28.2.260 Haak, 2007, Comparison of usability and patient preference for the new disposable insulin device SoloS TAR versus FlexPen, Lilly disposable pen, and a prototype pen: an open-label study, Clin Ther., 29, 650, 10.1016/j.clinthera.2007.04.003 Shelmet, 2004, Preference and resource utilization in elderly patients: InnoLet versus vial/syringe, Diabetes Res Clin Pract., 63, 27, 10.1016/j.diabres.2003.08.013 American Diabetes Association. 2009 Resource Guide. Accessed at www.forecast.diabetes.org/magazine/resource-guide/insulin-and-other-injected-drugs, March 3, 2009. Tubiana-Rufi, 1999, Short needles (8mm) reduce the risk of intramuscular injections in children with type 1 diabetes, Diabetes Care., 22, 1621, 10.2337/diacare.22.10.1621 Schwartz, 2004, A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6mm needle versus a 29 gauge × 12.7mm needle in obese patients with diabetes mellitus, Clin Ther., 26, 1663, 10.1016/j.clinthera.2004.10.007 Solvig, 2001, Needle Length affects insulin deposition in normal and obese diabetes patients [abstract], Diabetes., 50, A132 Asakura, 2005, Assessment of dose selection attributes with audible notification in insulin pen devices, Diabetes Technol Ther., 7, 620, 10.1089/dia.2005.7.620 Korytkowski, 2003, A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus, Clin Ther., 25, 2836, 10.1016/S0149-2918(03)80337-5 Keith, 2004, Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump, Clin Pediatr (Phila)., 43, 69, 10.1177/000992280404300109 Lteif, 1999, Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes, Diabetes Care., 22, 137, 10.2337/diacare.22.1.137 Graff, 1998, Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe, Clin Ther., 20, 486, 10.1016/S0149-2918(98)80058-1 Cobden, 2007, Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus, Pharmacotherapy., 27, 948, 10.1592/phco.27.7.948 Lee, 2006, Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data, Clin Ther., 28, 1712, 10.1016/j.clinthera.2006.10.004 Bohannon, 2000, Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery, Clin Ther., 22, 1049, 10.1016/S0149-2918(00)80084-3 Stockl, 2007, An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe, Curr Med Res Opin., 23, 133, 10.1185/030079906X159524 de Luis, 2004, Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2, J Diabetes Complications., 18, 216, 10.1016/S1056-8727(03)00089-8 Pawaskar, 2007, Heath care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis, Clin Ther., 10.1016/j.clinthera.2007.07.007 Kanakis, 2002, The business of insulin pumps in diabetes care: clinical and economic considerations, Clinical Diabetes., 20, 214, 10.2337/diaclin.20.4.214 U.S. Department of Health and Human Services, 2008 Novo Nordisk, 2008 Rubin, 2008, Factors affecting use of insulin pens by patients with type 2 diabetes, Diabetes Care., 31, 430, 10.2337/dc07-1899 Santiago, 2002, Accuracy and precision of the NovoPen 3 insulin delivery device after mechanical and temperature stresses, Endocr Pract., 8, 351, 10.4158/EP.8.5.351 Pellissier, 2006, Risk of needlestick injuries by injection pens, J Hosp Infect., 63, 60, 10.1016/j.jhin.2005.12.006 Diglas, 1999, Reduced pain perception with Pen Mate, an automatic needle insertion device for use with an insulin pen, Practical Diabetes International., 16, 39, 10.1002/pdi.1960160209 Dewitt, 2003, Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review, JAMA., 289, 2254, 10.1001/jama.289.17.2254 Plank, 2005, A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog determir, Diabetes Care., 28, 1107, 10.2337/diacare.28.5.1107 Sanofi-aventis. Opticlik. Accessed at www.opticlik.com, July 15, 2008. Sanofi-aventis. LANTUS SoloSTAR Pen. Accessed at www.lantus.com/solostar/solostar_insulin_pen.aspx, July 15, 2008. Novo Nordisk. Novo Nordisk Care. Accessed at www.novonordiskcare.com, July 15, 2008. DiabetesKidsandTeens.com. Accessed at www.diabeteskidsandteens.com.au/living_with_diabetes_1.html, July 15, 2008. Owen Mumford. Autopen. Accessed at www.owenmumford.com/en/range/6/autopen.html, July 15, 2008. Eli Lilly and Company. Insulin pens for the Humalog brand of insulins. Accessed at www.humalog.com/patient/humalog_insulin_pens.jsp, July 15, 2008. Becton, Dickinson and Company. BD Pen Needle prescribing information. Accessed at www.bddiabetes.com/us/hcp/main.aspx?cat=3067&id=3124, July 15, 2008. Hirsch IB, Skyler JS. The management of type 1 diabetes. In: Goldfine ID, Rushakoff RJ, Eds. Diabetes and carbohydrate metabolism. Updated August 27, 2006. Accessed at www.endotext.org/diabetes/index.htm, July 15, 2008.